ViiV Healthcare Submits Regulatory Application to European Medicines Agency for Investigational Cabotegravir to Be Used in Combination With Rilpivirine as the First Monthly, Injectable Treatment for H
Go back to ViiV Healthcare Submits Regulatory Application to European Medicines Agency for Investigational Cabotegravir to Be Used in Combination With Rilpivirine as the First Monthly, Injectable Treatment for H| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $50.74 | 52 Week Low | $37.82 | |||
| Day High | $50.74 | P/E | N/A | |||
| Day Low | $50.74 | EPS | $0.00 | |||
| Volume | 10,437 | |||||
| GLAXOSMITHKLINE PLC (NYSE: GSK) | Delayed: 50.74 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $50.74 | 52 Week High | $45.58 | |||
| Open | $50.74 | 52 Week Low | $37.82 | |||
| Day High | $50.74 | P/E | N/A | |||
| Day Low | $50.74 | EPS | $0.00 | |||
| Volume | 10,437 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 25.08 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $25.08 | 52 Week High | $37.39 | |||
| Open | $25.08 | 52 Week Low | $28.25 | |||
| Day High | $25.08 | P/E | 15.20 | |||
| Day Low | $25.08 | EPS | $1.65 | |||
| Volume | 257,428 | |||||
